1. Home
  2. VALN

as of 03-10-2026 3:05pm EST

$11.30
+$0.80
+7.62%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Founded: 2012 Country:
France
France
Employees: N/A City: N/A
Market Cap: 875.7M IPO Year: 2021
Target Price: $15.75 AVG Volume (30 days): 17.1K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $5.43 - $12.25 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 2.58% Revenue Growth (next year): 4.43%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: